Dopamine triggers heterosynaptic plasticity

J Neurosci. 2013 Apr 17;33(16):6759-65. doi: 10.1523/JNEUROSCI.4694-12.2013.

Abstract

As a classic neuromodulator, dopamine has long been thought to modulate, rather than trigger, synaptic plasticity. In contrast, our present results demonstrate that within the parallel projections of dopaminergic and GABAergic terminals from the ventral tegmental area to the nucleus accumbens core (NAcCo), action-potential-activated release of dopamine heterosynaptically triggers LTD at GABAergic synapses, which is likely mediated by activating presynaptically located dopamine D1 class receptors and expressed by inhibiting presynaptic release of GABA. Moreover, this dopamine-mediated heterosynaptic LTD is abolished after withdrawal from cocaine exposure. These results suggest that action-potential-dependent dopamine release triggers very different cellular consequences from those induced by volume release or pharmacological manipulation. Activation of the ventral tegmental area to NAcCo projections is essential for emotional and motivational responses. This dopamine-mediated LTD allows a flexible output of NAcCo neurons, whereas disruption of this LTD may contribute to the rigid emotional and motivational state observed in addicts during cocaine withdrawal.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Benzoates / pharmacology
  • Channelrhodopsins
  • Cocaine / administration & dosage
  • Dopamine / metabolism*
  • Dopamine Uptake Inhibitors / administration & dosage
  • Electric Stimulation
  • GABAergic Neurons / drug effects
  • GABAergic Neurons / physiology*
  • Genetic Vectors / physiology
  • Glycine / analogs & derivatives
  • Glycine / pharmacology
  • In Vitro Techniques
  • Inhibitory Postsynaptic Potentials / drug effects
  • Inhibitory Postsynaptic Potentials / physiology
  • Long-Term Synaptic Depression / drug effects
  • Long-Term Synaptic Depression / physiology*
  • Male
  • Nucleus Accumbens / cytology
  • Optogenetics
  • Phosphinic Acids / pharmacology
  • Photic Stimulation
  • Propanolamines / pharmacology
  • Pyridines / pharmacology
  • Quinoxalines / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Synapses / drug effects
  • Synapses / physiology*
  • Time Factors
  • Transduction, Genetic
  • Tyrosine 3-Monooxygenase / metabolism
  • Ventral Tegmental Area / cytology

Substances

  • Benzoates
  • Channelrhodopsins
  • Dopamine Uptake Inhibitors
  • Phosphinic Acids
  • Propanolamines
  • Pyridines
  • Quinoxalines
  • 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
  • alpha-methyl-4-carboxyphenylglycine
  • CGP 55845A
  • 6-methyl-2-(phenylethynyl)pyridine
  • Tyrosine 3-Monooxygenase
  • Cocaine
  • Glycine
  • Dopamine